PI5P4Kα: a target in prostate cancer?
- PMID: 36918684
- DOI: 10.1038/s41585-023-00759-6
PI5P4Kα: a target in prostate cancer?
Comment on
-
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.Sci Adv. 2023 Feb 3;9(5):eade8641. doi: 10.1126/sciadv.ade8641. Epub 2023 Feb 1. Sci Adv. 2023. PMID: 36724278 Free PMC article.